Source: Resumos. Conference titles: Meeting of the Brazilian Society of Immunology. Unidades: ICB, FCFRP
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTI, L. et al. Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression. 2005, Anais.. São Pedro: Brazilian Society of Immunology, 2005. . Acesso em: 17 maio 2024.APA
Marti, L., Castro, F. A. de, Jacysyn, J. F., Tobo, P. R., Lopes, L. R., Hamerschlak, N., et al. (2005). Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression. In Resumos. São Pedro: Brazilian Society of Immunology.NLM
Marti L, Castro FA de, Jacysyn JF, Tobo PR, Lopes LR, Hamerschlak N, Zanichelli MA, Candido DLA, Okamoto OK, Amarante-Mendes JGP, Moreira-Filho CA. Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression. Resumos. 2005 ;[citado 2024 maio 17 ]Vancouver
Marti L, Castro FA de, Jacysyn JF, Tobo PR, Lopes LR, Hamerschlak N, Zanichelli MA, Candido DLA, Okamoto OK, Amarante-Mendes JGP, Moreira-Filho CA. Indoleamine 2,3-dioxygenase expression in chronic myelogenous leukemia patients: association with disease progression. Resumos. 2005 ;[citado 2024 maio 17 ]